Alpine Immune Sciences (ALPN) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Alpine Immune Sciences (ALPN) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 26, 2024 (22:18)

Sector: Healthcare

The share price of Alpine Immune Sciences, Inc. (ALPN) now

Latest session on the 25th of July for
Alpine Immune Sciences, Inc. is negative
Trading Volume: 938
Open: 64.97 /  High: 64.97 /  Low: 64.97
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Alpine Immune Sciences stocks, the 50-day moving average is the support level today.

For Alpine Immune Sciences stocks, the 200-day moving average is the support level today.

Are you interested in Alpine Immune Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alpine Immune Sciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Alpine Immune Sciences share be worth in 2024 - 2028?

When should I take profit in Alpine Immune Sciences stock? When should I record a loss on Alpine Immune Sciences stock? What are analysts' forecasts for Alpine Immune Sciences stock? What is the future of Alpine Immune Sciences stock? We forecast Alpine Immune Sciences stock performance using neural networks based on historical data on Alpine Immune Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alpine Immune Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alpine Immune Sciences shares. This happens once a day.


Historical and forecast chart of Alpine Immune Sciences stock

The chart below shows the historical price of Alpine Immune Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alpine Immune Sciences stock price can be found in the table below.

Long-term forecasts by years.

Alpine Immune Sciences, Inc. Is a biopharmaceutical company. The company is focused on the discovery and development of protein immunotherapy for the treatment of cancer, autoimmune and inflammatory diseases. The Company’s scientific platform uses a directed evolutionary process to convert native immune system proteins from the immunoglobulin superfamily (IgSF) into multipurpose therapeutic drugs capable of modulating the human immune system. Its candidate products include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulant (ICOS) and differentiation cluster 28 (CD28) antagonist for the treatment of autoimmune and inflammatory diseases. His cancer program is ALPN-202, a conditional CD28 co-stimulator and dual checkpoint inhibitor for cancer treatment. ALPN-303 is a dual antagonist of B-cell cytokines for the treatment of B-cell mediated diseases.

Alpine Immune Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 28 68.29 67.65 68.70 1.54
Jul 29 68.10 66.86 69.02 3.24
Jul 30 66.96 66.01 68.42 3.65
Jul 31 65.07 64.39 65.58 1.85
Aug 01 66.83 66.06 67.29 1.85
Aug 02 66.81 65.20 68.05 4.36
Aug 03 66.57 65.51 67.22 2.62
Aug 04 67.20 65.83 67.97 3.25
Aug 05 69.04 67.78 70.05 3.36
Aug 06 69.00 68.23 70.63 3.52
Aug 07 68.63 67.43 69.37 2.87
Aug 08 69.72 68.08 70.34 3.32
Aug 09 68.78 67.15 69.56 3.60
Aug 10 68.84 67.25 70.16 4.33
Aug 11 68.13 66.93 68.63 2.53
Aug 12 69.97 68.65 71.36 3.94
Aug 13 71.46 70.01 72.45 3.49
Aug 14 72.79 71.46 74.00 3.54
Aug 15 72.95 71.42 74.63 4.50
Aug 16 71.31 70.66 72.57 2.69
Aug 17 70.24 68.70 70.91 3.22
Aug 18 68.26 66.97 69.16 3.27
Aug 19 68.21 66.97 69.26 3.42
Aug 20 67.19 66.39 68.12 2.61
Aug 21 66.93 65.36 68.05 4.12
Aug 22 66.45 65.73 67.26 2.34
Aug 23 66.79 66.25 68.11 2.81
Aug 24 67.45 66.19 68.54 3.55
Aug 25 67.37 66.82 67.77 1.42
Aug 26 65.43 64.92 66.03 1.72

Alpine Immune Sciences Daily Price Targets


Alpine Immune Sciences Stock Forecast 07-28-2024.

Forecast target price for 07-28-2024: $68.29.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 1.521%.
Pessimistic target level: 67.65
Optimistic target level: 68.70

Alpine Immune Sciences Stock Forecast 07-29-2024.

Forecast target price for 07-29-2024: $68.10.
Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.138%.
Pessimistic target level: 66.86
Optimistic target level: 69.02

Alpine Immune Sciences Stock Forecast 07-30-2024.

Forecast target price for 07-30-2024: $66.96.
Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.523%.
Pessimistic target level: 66.01
Optimistic target level: 68.42

Alpine Immune Sciences Stock Forecast 07-31-2024.

Forecast target price for 07-31-2024: $65.07.
Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 1.816%.
Pessimistic target level: 64.39
Optimistic target level: 65.58

Alpine Immune Sciences Stock Forecast 08-01-2024.

Forecast target price for 08-01-2024: $66.83.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 1.817%.
Pessimistic target level: 66.06
Optimistic target level: 67.29

Alpine Immune Sciences Stock Forecast 08-02-2024.

Forecast target price for 08-02-2024: $66.81.
Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 4.182%.
Pessimistic target level: 65.20
Optimistic target level: 68.05

ALPN (ALPN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 60.40 53.44 63.39 15.70
Sep. 57.88 54.64 59.74 8.53
Oct. 53.81 51.83 57.42 9.75
Nov. 54.93 50.53 57.30 11.81
Dec. 56.51 53.89 61.03 11.70

Alpine Immune Sciences forecast for this year


Alpine Immune Sciences Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $60.3961. Pessimistic: $53.44. Optimistic: $63.39


Alpine Immune Sciences Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $57.8836. Pessimistic: $54.64. Optimistic: $59.74


Alpine Immune Sciences Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $53.8086. Pessimistic: $51.83. Optimistic: $57.42


Alpine Immune Sciences Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $54.9278. Pessimistic: $50.53. Optimistic: $57.30


Alpine Immune Sciences Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $56.5098. Pessimistic: $53.89. Optimistic: $61.03



Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 52.89 46.63 55.43 15.88
Feb 56.87 52.87 61.69 14.31
Mar 54.78 50.75 57.14 11.20
Apr 57.41 55.11 64.11 14.04
May 50.24 48.47 52.25 7.23
Jun 49.52 47.86 51.42 6.93
Jul 45.72 42.64 50.40 15.38
Aug 52.74 50.54 55.78 9.38
Sep 50.46 47.07 56.27 16.36
Oct 52.24 48.31 56.50 14.50
Nov 57.67 50.84 63.02 19.33
Dec 64.31 61.23 66.68 8.18

Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 60.40 54.12 67.36 19.66
Feb 55.67 50.59 59.67 15.22
Mar 49.08 43.27 53.00 18.37
Apr 47.19 45.61 52.40 12.97
May 47.64 42.92 49.40 13.12
Jun 48.25 46.09 53.04 13.10
Jul 52.35 48.66 54.19 10.20
Aug 50.50 48.32 53.82 10.21
Sep 50.66 47.42 54.31 12.69
Oct 47.99 46.22 49.83 7.24
Nov 41.23 36.22 44.27 18.18
Dec 43.34 40.08 47.02 14.75

Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 45.77 41.89 49.14 14.75
Feb 49.14 47.02 54.33 13.46
Mar 52.05 48.72 55.13 11.63
Apr 56.55 50.94 59.44 14.31
May 54.47 51.68 57.08 9.47
Jun 63.01 60.79 70.97 14.35
Jul 65.53 63.43 71.40 11.16
Aug 65.11 62.81 67.50 6.94
Sep 73.86 68.78 77.99 11.82
Oct 84.96 75.18 88.23 14.79
Nov 90.95 84.11 101.71 17.31
Dec 98.22 94.45 101.37 6.82

Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 97.44 92.45 109.13 15.29
Feb 98.99 90.92 107.39 15.34
Mar 104.70 98.00 108.38 9.58
Apr 102.02 89.77 108.87 17.54
May 95.00 84.81 104.73 19.01
Jun 87.85 84.90 96.99 12.46
Jul 97.55 93.18 108.32 13.98
Aug 101.30 90.76 112.65 19.42
Sep 109.73 97.96 117.80 16.84
Oct 119.91 107.63 127.78 15.77
Nov 110.32 96.20 118.97 19.14
Dec 107.32 101.14 116.59 13.26

Alpine Immune Sciences information and performance

Alpine Immune Sciences Address

N/A

Market Capitalization: N/A $

Market capitalization of the Alpine Immune Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALPN shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Alpine Immune Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.